Mark D Pegram Selected Research

Immunotherapy

11/2019	Induced pluripotent stem cells as a novel cancer vaccine.
1/2010	Targeted Therapy in Metastatic Breast Cancer: The HER2/neu Oncogene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mark D Pegram Research Topics

Disease

43	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2002
35	Neoplasms (Cancer) 01/2021 - 06/2002
6	Disease Progression 04/2021 - 05/2004
3	Triple Negative Breast Neoplasms 01/2021 - 01/2017
2	Brain Neoplasms (Brain Tumor) 04/2023 - 12/2016
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 01/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2015 - 01/2015
2	Lung Neoplasms (Lung Cancer) 12/2006 - 11/2005
2	Cardiotoxicity 10/2005 - 12/2004
1	Drug-Related Side Effects and Adverse Reactions 01/2024
1	Fatigue 01/2021
1	Vomiting 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Nausea 01/2021
1	Neoplasm Micrometastasis 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2019
1	Circulating Neoplastic Cells 03/2016
1	Leukemia 11/2014
1	Pathologic Complete Response 04/2013
1	Ovarian Neoplasms (Ovarian Cancer) 09/2006
1	Diarrhea 09/2006
1	Inflammatory Breast Neoplasms 04/2006

Drug/Important Bio-Agent (IBA)

18	Trastuzumab (Herceptin)FDA Link 10/2023 - 06/2002
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2002
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 01/2003
5	Docetaxel (Taxotere)FDA Link 01/2017 - 05/2004
4	Hormones (Hormone)IBA 01/2024 - 12/2012
4	EnzymesIBA 01/2020 - 09/2006
4	Carboplatin (JM8)FDA LinkGeneric 01/2011 - 05/2004
3	ErbB Receptors (EGF Receptor)IBA 10/2023 - 04/2006
3	Estrogen ReceptorsIBA 01/2022 - 05/2018
3	Ado-Trastuzumab EmtansineIBA 01/2021 - 01/2016
3	Monoclonal AntibodiesIBA 01/2021 - 06/2002
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2016
3	ProdrugsIBA 01/2020 - 01/2003
3	Messenger RNA (mRNA)IBA 01/2020 - 01/2016
3	PlatinumIBA 04/2013 - 05/2004
3	Lapatinib (GW572016)FDA Link 12/2012 - 02/2006
3	AnthracyclinesIBA 01/2009 - 12/2004
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2007 - 08/2004
3	human ERBB2 proteinIBA 01/2007 - 04/2006
3	Cisplatin (Platino)FDA LinkGeneric 04/2006 - 05/2004
2	margetuximabIBA 10/2023 - 04/2021
2	neratinibIBA 01/2022 - 12/2016
2	Protein Isoforms (Isoforms)IBA 01/2021 - 01/2018
2	magrolimabIBA 01/2021 - 01/2019
2	Immunoconjugates (Immunoconjugate)IBA 01/2021 - 01/2020
2	Epidermal Growth Factor (EGF)IBA 01/2021 - 12/2012
2	pertuzumabIBA 01/2021 - 09/2006
2	Phosphotransferases (Kinase)IBA 12/2012 - 02/2006
2	taxaneIBA 01/2009 - 08/2004
2	SaltsIBA 12/2004 - 05/2004
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2004 - 06/2002
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2024
1	Fulvestrant (Faslodex)FDA Link 01/2022
1	CopperIBA 01/2021
1	Estrogen Receptor alphaIBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2021
1	Chelating AgentsIBA 01/2021
1	MEDI4276IBA 01/2021
1	AntibodiesIBA 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2021
1	Single-Chain AntibodiesIBA 01/2020
1	tretazicarIBA 01/2020
1	multidrug resistance-associated protein 1IBA 01/2020
1	Neoplasm Antigens (Tumor Antigens)IBA 11/2019
1	VaccinesIBA 11/2019
1	Cadherins (E-Cadherin)IBA 01/2019
1	PF-05280014IBA 01/2019
1	Biosimilar PharmaceuticalsIBA 01/2019
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2018
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2017
1	nirogacestatIBA 01/2017
1	PTEN Phosphohydrolase (PTEN Phosphatase)IBA 01/2016
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2016
1	Tumor Biomarkers (Tumor Markers)IBA 01/2016
1	Phenobarbital (Luminal)FDA Link 01/2015
1	Arsenic Trioxide (Trisenox)FDA Link 11/2014
1	ArsenicIBA 11/2014
1	Drinking WaterIBA 11/2014
1	Mechanistic Target of Rapamycin Complex 1IBA 12/2012
1	ADP Ribose Transferases (ADP Ribosyltransferase)IBA 09/2011
1	DNA (Deoxyribonucleic Acid)IBA 09/2011
1	epitumomabIBA 01/2009
1	ImmunosorbentsIBA 09/2006
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2006
1	Filgrastim (Neupogen)FDA Link 04/2006
1	Tamoxifen FDA LinkGeneric 04/2006
1	ThymidineIBA 01/2006

Therapy/Procedure

25	Therapeutics 01/2024 - 01/2003
15	Drug Therapy (Chemotherapy) 10/2023 - 05/2004
3	Radiotherapy 01/2015 - 04/2006
3	Aftercare (After-Treatment) 12/2006 - 01/2003
2	Immunotherapy 11/2019 - 01/2010
2	Operative Surgical Procedures 01/2015 - 01/2015
1	Neoadjuvant Therapy 01/2020
1	Prophylactic Mastectomy 01/2015